1,2,4-triazine has been researched along with thiazoles in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciftci, GA; Demir, B; Levent, S; Saglik, BN; Temel, HE; Yurttas, L | 1 |
| Gong, Z; Li, Y; Peng, Z; Wang, G | 1 |
| Ashour, HMA; El-Wakil, MH; El-Yazbi, AF; Ismail, KA; Khalil, MA; Labouta, IM | 1 |
3 other study(ies) available for 1,2,4-triazine and thiazoles
| Article | Year |
|---|---|
Biological Activity Evaluation of Novel 1,2,4-Triazine Derivatives Containing Thiazole/Benzothiazole Rings.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzothiazoles; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; MCF-7 Cells; Mice; NIH 3T3 Cells; Structure-Activity Relationship; Thiazoles; Triazines | 2017 |
Synthesis, biological evaluation, and docking studies of novel 5,6-diaryl-1,2,4-triazine thiazole derivatives as a new class of α-glucosidase inhibitors.
Topics: alpha-Glucosidases; Dose-Response Relationship, Drug; Glycoside Hydrolase Inhibitors; Humans; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship; Thiazoles; Triazines | 2018 |
Discovery of a novel DNA binding agent via design and synthesis of new thiazole hybrids and fused 1,2,4-triazines as potential antitumor agents: Computational, spectrometric and in silico studies.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; DNA; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Neoplasms; Structure-Activity Relationship; Thiazoles; Triazines; Tumor Cells, Cultured | 2019 |